Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION
| Report ID | 30892 |
| Drug Identification Number | 02299658 |
| Brand name | PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION |
| Common or Proper name | PIPERACILLIN-TAZOBACTAM |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | PIPERACILLIN TAZOBACTAM |
| Strength(s) | 4G 0.5G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 10 VIALS |
| ATC code | J01CR |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2017-11-24 |
| Estimated end date | 2018-07-20 |
| Actual end date | 2018-08-10 |
| Shortage status | Resolved |
| Updated date | 2018-08-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-11-28 | English | Compare |